Antimicrobial Resistance and Its Impact on the Management of Bacterial Infections

Abstract

Antimicrobial resistance (AMR) has emerged as one of the most significant global public health challenges, substantially affecting the management and outcomes of bacterial infections. The inappropriate and excessive use of antimicrobial agents in human and veterinary medicine, inadequate infection-control practices, and the transmission of resistant microorganisms have accelerated the development and spread of antimicrobial resistance. Resistant bacterial infections can lead to prolonged illness, increased healthcare costs, treatment failures, extended hospital stays, and higher morbidity and mortality. The emergence of multidrug-resistant organisms, including methicillin-resistant Staphylococcus aureus, extended-spectrum β-lactamase-producing Enterobacterales, carbapenem-resistant Gram-negative bacteria, and drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, has further complicated clinical decision-making. Effective management increasingly requires appropriate diagnostic testing, antimicrobial susceptibility testing, timely selection of targeted therapy, antimicrobial stewardship, and strengthened infection-prevention measures. New antibiotics, alternative therapeutic approaches, vaccination, rapid diagnostic technologies, and surveillance systems may also contribute to controlling the spread of resistance. Addressing AMR requires coordinated efforts among healthcare professionals, researchers, policymakers, patients, and public-health institutions. This article discusses the causes and consequences of antimicrobial resistance and examines its impact on the diagnosis, treatment, and overall management of bacterial infections.